Cargando…
Programmable RNA editing with endogenous ADAR enzymes – a feasible option for the treatment of inherited retinal disease?
RNA editing holds great promise for the therapeutic correction of pathogenic, single nucleotide variants (SNV) in the human transcriptome since it does not risk creating permanent off-targets edits in the genome and has the potential for innovative delivery options. Adenine deaminases acting on RNA...
Autores principales: | Bellingrath, Julia-Sophia, McClements, Michelle E., Fischer, M. Dominik, MacLaren, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244592/ https://www.ncbi.nlm.nih.gov/pubmed/37293541 http://dx.doi.org/10.3389/fnmol.2023.1092913 |
Ejemplares similares
-
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
por: Hansen, Silja, et al.
Publicado: (2023) -
In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention
por: Bellingrath, Julia-Sophia, et al.
Publicado: (2021) -
CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in Rhodopsin
por: Kaukonen, Maria, et al.
Publicado: (2022) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020) -
Genome-Editing Strategies for Treating Human Retinal Degenerations
por: Quinn, Joel, et al.
Publicado: (2021)